255 related articles for article (PubMed ID: 17323453)
21. [In vivo evaluation of Plasmodium falciparum sensitivity to chloroquine in Moundou, Chad].
Renaudin P; Lombart JP
Med Trop (Mars); 1995; 55(3):286. PubMed ID: 8559029
[No Abstract] [Full Text] [Related]
22. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
Laufer MK; Plowe CV
Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
[TBL] [Abstract][Full Text] [Related]
23. Chloroquine prophylaxis associated with high prevalence of Plasmodium falciparum pfcrt K76T mutation in people with sickle-cell disease in Benin City, Nigeria.
Tatfeng YM; Agbonlahor DE; Tchounga KS; Omolu PI; Okodua M; Yah CS; Adeolu A
J Vector Borne Dis; 2008 Mar; 45(1):51-5. PubMed ID: 18399317
[TBL] [Abstract][Full Text] [Related]
24. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya.
Zucker JR; Ruebush TK; Obonyo C; Otieno J; Campbell CC
Am J Trop Med Hyg; 2003 Apr; 68(4):386-90. PubMed ID: 12879851
[TBL] [Abstract][Full Text] [Related]
25. [Chloroquine resistant strains of Plasmodium falciparum in the Anopheles vector and use of antimalarials].
Molez JF; Robert V; Trape JF
Dakar Med; 1996; Spec No():7-9. PubMed ID: 14520978
[No Abstract] [Full Text] [Related]
26. An in vivo chloroquine sensitivity study in relation to low transmission potential and imported malaria in Kerala.
Nagaraj C; Sugathan N; Chakrabarti NK; Narasimham MV
J Commun Dis; 1991 Jun; 23(2):100-2. PubMed ID: 1940213
[TBL] [Abstract][Full Text] [Related]
27. A molecular marker for chloroquine-resistant falciparum malaria.
Warhurst DC
N Engl J Med; 2001 Jan; 344(4):299-302. PubMed ID: 11172160
[No Abstract] [Full Text] [Related]
28. Revising antimalarial drug policy in Central America: experience in Panama.
Calzada JE; Samudio F; Bayard V; Obaldia N; de Mosca IB; Pascale JM
Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):694-8. PubMed ID: 18436272
[TBL] [Abstract][Full Text] [Related]
29. Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria.
Ojurongbe O; Ogungbamigbe TO; Fagbenro-Beyioku AF; Fendel R; Kremsner PG; Kun JF
Malar J; 2007 Apr; 6():41. PubMed ID: 17428334
[TBL] [Abstract][Full Text] [Related]
30. [The status of malaria chemoresistance in Africa].
Le Bras J
Med Trop (Mars); 1995; 55(4 Suppl):9-13. PubMed ID: 8649277
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiological surveillance of Plasmodium falciparum sensitivity to chloroquine in Cameroon: necessity of public health policy adaptation].
Louis FJ; Ringwald P; Chambon R
Med Trop (Mars); 1995; 55(4 Suppl):77-9. PubMed ID: 8649272
[No Abstract] [Full Text] [Related]
32. Death from malaria following inappropriate chemoprophylaxis.
Kaye D
Clin Infect Dis; 2001 Sep; 33(5):i. PubMed ID: 11545069
[No Abstract] [Full Text] [Related]
33. Chemoresistance in falciparum malaria.
May J; Meyer CG
Trends Parasitol; 2003 Oct; 19(10):432-5; discussion 435-6. PubMed ID: 14519577
[No Abstract] [Full Text] [Related]
34. A unique methodology for detecting the spread of chloroquine-resistant strains of Plasmodium falciparum, in previously unreported areas, by analyzing anophelines of malaria endemic zones of Orissa, India.
Mohanty A; Swain S; Singh DV; Mahapatra N; Kar SK; Hazra RK
Infect Genet Evol; 2009 Jul; 9(4):462-7. PubMed ID: 19460311
[TBL] [Abstract][Full Text] [Related]
35. Resurgence of malaria in Mumbai--is escalating chloroquine resistance a cause?
Sorabjee JS
J Assoc Physicians India; 2000 Mar; 48(3):365-6. PubMed ID: 11229137
[No Abstract] [Full Text] [Related]
36. Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum.
Verdrager J
Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):23-8. PubMed ID: 8525414
[TBL] [Abstract][Full Text] [Related]
37. [Will a gametocytocide combined with an antimalarial schizonticide soon be necessary in areas of drug resistance?].
Molez JF; Gaye O
Med Trop (Mars); 1997; 57(1):97. PubMed ID: 9289621
[No Abstract] [Full Text] [Related]
38. Resurgence of malaria and drug resistance in Plasmodium falciparum and vivax species in Bombay.
Sorabjee JS
J Assoc Physicians India; 1996 Jan; 44(1):71. PubMed ID: 8773108
[No Abstract] [Full Text] [Related]
39. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
40. The treatment of chloroquine-resistant malaria.
van Vugt M; White NJ
Trop Doct; 1999 Jul; 29(3):176-9. PubMed ID: 10448249
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
